Stopping GLP-1 drugs raises heart risk
Feedpost

Stopping GLP-1 drugs raises heart risk

  • Stopping GLP-1 drugs like Ozempic doubles heart attack and stroke risk
  • A US study shows risks grow by 22% after two years of discontinuation
  • Patients must consult doctors before stopping to manage chronic risks
Summarized by AI ⓘ
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.